BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25552885)

  • 1. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis.
    Kim YZ; Kwon JH; Lim S
    J Korean Med Sci; 2015 Jan; 30(1):66-73. PubMed ID: 25552885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of 23 gynecologic carcinoma patients with brain metastasis].
    Zhang JX; Wang SZ; Li B; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1843-6. PubMed ID: 27356795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic factors influencing overall survival in uterine cervical cancer with brain metastasis.
    Kim H; Lee KK; Heo MH; Kim JY
    Korean J Intern Med; 2019 Nov; 34(6):1324-1332. PubMed ID: 30360020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of 25 cases of brain metastasis from gynecological cancers].
    Yuan GW; Wu LY; Huang MN; Yao HW
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):191-5. PubMed ID: 22781070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of distant metastases in patients with gynecologic cancers after surgery: a population-based study.
    Hsiao YH; Chen PN; Hsin MC; Wang PH; Huang JY; Yang SF
    Aging (Albany NY); 2021 Dec; 13(24):25846-25858. PubMed ID: 34914632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    Hayashi N; Takahashi H; Hasegawa Y; Higuchi F; Takahashi M; Makino K; Takagaki M; Akimoto J; Okuda T; Okita Y; Mitsuya K; Hirashima Y; Narita Y; Nakasu Y;
    BMC Cancer; 2017 Jun; 17(1):397. PubMed ID: 28577359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
    Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
    Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.
    Binesh F; Akhavan A; Behniafard N; Zabihi S; Hosseinizadeh E
    Asian Pac J Cancer Prev; 2014; 15(21):9405-10. PubMed ID: 25422232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prognosis of brain metastases from gynecological cancers.
    Ogawa K; Yoshii Y; Aoki Y; Nagai Y; Tsuchida Y; Toita T; Kakinohana Y; Tamaki W; Iraha S; Adachi G; Hirakawa M; Kamiyama K; Inamine M; Hyodo A; Murayama S
    Neurol Med Chir (Tokyo); 2008 Feb; 48(2):57-62; discussion 62-3. PubMed ID: 18296873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.
    Divine LM; Kizer NT; Hagemann AR; Pittman ME; Chen L; Powell MA; Mutch DG; Rader JS; Thaker PH
    Gynecol Oncol; 2016 Jul; 142(1):76-82. PubMed ID: 27117923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors in gynecologic cancer].
    Yajima A; Sato S
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2209-15. PubMed ID: 3408255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of gynecological cancers in Turkey: where are we at?
    Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
    J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial).
    Nasu K; Satoh T; Nishio S; Nagai Y; Ito K; Otsuki T; Hongo A; Hirashima Y; Ogura T; Shimada M
    Gynecol Oncol; 2013 Feb; 128(2):198-203. PubMed ID: 23142074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in gynecologic cancers.
    Ackerman I; Dembo A
    Curr Opin Oncol; 1989 Oct; 1(1):82-8. PubMed ID: 2489953
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival of Danish cancer patients 1943-1987. Female genital organs.
    Kjaer SK; Storm HH
    APMIS Suppl; 1993; 33():107-21. PubMed ID: 8512734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system metastasis in gynecologic cancer: symptom management, prognosis and palliative management strategies.
    Walter AC; Gunderson CC; Vesely SK; Algan O; Sughrue M; Slaughter KN; Moore KN
    Gynecol Oncol; 2015 Mar; 136(3):472-7. PubMed ID: 25752572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of gynecologic malignancy at the University of Kentucky Medical Center.
    van Nagell JR; Donaldson ES; Maruyama Y; Utley J
    J Ky Med Assoc; 1976 Jun; 74(6):286-9. PubMed ID: 932540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.